The FDA has mandated updated safety labeling for two respiratory syncytial virus vaccines, Pfizer's Abrysvo and GlaxoSmithKline's Arexvy, following the identification of an increased risk of ...

Saisei Ventures, a leading investment firm focused on advancing Japanese biotechnology and therapeutic innovations, announced today that Dr. Sven Kili has been appointed partner at the firm. Dr. Kili ...

This latest investment, which brings OXcan’s total funding to date to $16.7 million, will be used to develop and globally ...

North America severe asthma market is set for growth, driven by high asthma prevalence, increased awareness, and advanced treatment options for severe cases. Ankush Nikam Future Market Insights, Inc.

--Pharmaceutical giant GSK PLC is in talks to buy U.S. privately owned biotech company IDRx, which is developing a treatment for rare gastrointestinal tumors, for up to $1 billion, the Financial Times ...

Moderna stock was on track to see a weekly gain of 10% as of Wednesday following the first reported bird flu death in the US.

CureVac recently released new clinical data. Why should investors care? Click here to find out why I am bullish on CVAC stock ...

Moderna stock was on track to see a weekly gain of over 20% as of Wednesday following the first reported bird flu death in the US.

ShareThe recent wave of delistings from the Nigerian Exchange (NGX) by notable companies such as Flour Mills of Nigeria (FMN) and GlaxoSmithKline (GSK) has sparked conversations among investors, ...